JPRN-jRCT2080221260未知3 期
A clinical pharmacological study of SK-0403
适应症
试验速览
- 阶段
- 3 期
- 入组人数
- 20
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 20age old 至 <= 69age old（—）
- 性别
- Male
入选标准
- •Patients with type 2 diabetes mellitus who have inadequate glycemic control by diet and/or exercise therapies
- •HbA1C of >= 6.5%, but < 10.0%
- •fasting blood glucose of >=126mg/dL, but <200mg/dL
- •1-hour postprandial blood glucose or 2-hour postprandial blood glucose of >=200mg/d
排除标准
- •Patients with type 1 diabetes mellitus
- •Patients with, or a history of, clinically significant cardiac, renal, hepatic, pulmonary, pancreatic and macrovascular disease
- •Patients who had taken SK-0403
研究者
相似试验
未知
2 期
Efficacy and Safety of SK-0403 in Patients with Type 2 DiabetesType 2 diabetesJPRN-jRCT2080220892SANWA KAGAKU KENKYUSHO Co., Ltd.
已完成
1 期
Pharmacokinetic study of SK-1405 in patients undergoing hemodialysisJPRN-jRCT2080223782Sanwa Kagaku Kenkyusho Co., Ltd.12
未知
3 期
Efficacy and Long-Term Safety of SK-0403 as Add-on Therapy to Sulfonylurea or Biguanides in Patients With Type 2 DiabetesType 2 Diabetes MellitusJPRN-jRCT2080220755Kowa Co., Ltd.
未知
3 期
Efficacy and Long-Term Safety of SK-0403 as Add-on Therapy to Alpha-Glucosidase Inhibitor or Pioglitazone in Patients with Type 2 DiabetesType 2 diabetesJPRN-jRCT2080220767SANWA KAGAKU KENKYUSHO Co., Ltd.
未知
3 期
Efficacy and Long-Term Safety of SK-0403 as Add-on Therapy to Insulin in Patients with Type 2 DiabetesType 2 diabetesJPRN-jRCT2080222199SANWA KAGAKU KENKYUSHO CO.,LTD.